Search Results - "Cyr, Philip L."

Burden of illness and mortality in men with Adrenomyeloneuropathy: a retrospective cohort study by Bonkowsky, Joshua L, Healey, Bridget, Sacks, Naomi C, McLin, Ronaé, Cyr, Philip L, Sawyer, Eileen K, Stephen, Christopher D, Eichler, Florian

“…Adrenomyeloneuropathy (AMN) is a neurodegenerative disease phenotype of X-linked adrenoleukodystrophy (ALD), resulting in progressive myeloneuropathy causing…”
Get full text

The Economic Burden of Treatment-Resistant Depression by Olchanski, Natalia, MS, McInnis Myers, Michelle, MPA, Halseth, Marilyn, MBA, Cyr, Philip L., MPH, Bockstedt, Lindsay, PhD, Goss, Thomas F., PharmD, Howland, Robert H., MD

“…Abstract Background Major depressive disorder (MDD) is a leading cause of disability, morbidity, and mortality worldwide. The lifetime prevalence in the United…”
Get full text

Effect of serum sodium concentration and tolvaptan treatment on length of hospitalization in patients with heart failure by Cyr, Philip L, Slawsky, Katherine A, Olchanski, Natalia, Krasa, Holly B, Goss, Thomas F, Zimmer, Christopher, Hauptman, Paul J

“…The effect of serum sodium concentration and tolvaptan treatment on length of stay (LOS) in patients hospitalized with heart failure (HF) was evaluated. Data…”
Get full text

Comparison of claims data on hospitalization rates and repeat procedures in patients receiving a bowel preparation prior to colonoscopy by Young, Lisa E, Sacks, Naomi C, Cyr, Philip L, Sharma, Abhishek, Dahdal, David N

“…Objectives: To evaluate outcomes of colorectal screening using sodium picosulfate and magnesium citrate compared with other prescription bowel-preparation…”
Get full text

Prevalence and incidence of patients with paroxysmal supraventricular tachycardia in the United States by Rehorn, Michael, Sacks, Naomi C., Emden, Maia R., Healey, Bridget, Preib, Madison T., Cyr, Philip L., Pokorney, Sean D.

“…Background Paroxysmal supraventricular tachycardia (PSVT) encompasses a range of heart rhythm disorders leading to rapid heart rates. By virtue of its episodic…”
Get full text

Catheter ablation for supraventricular tachycardia and health resource utilization and expenditures: A propensity-matched cohort study by Chew, Derek S., Sacks, Naomi C., Emden, Maia R., Cyr, Philip L., Sherwood, Rick, Pokorney, Sean D.

“…Few data are available regarding temporal patterns of health resource utilization (HRU) and expenditures among patients undergoing catheter ablation for…”
Get full text

Trends in health care resource use and expenditures in patients with newly diagnosed paroxysmal supraventricular tachycardia in the United States by Chew, Derek S., Sacks, Naomi C., Emden, Maia R., Preib, Madison T., Cyr, Philip L., Wood, David, Pokorney, Sean D.

“…Few data are available on the temporal patterns of health resource utilization (HRU) and expenditures around paroxysmal supraventricular tachycardia (PSVT)…”
Get full text

Healthcare Resource Use and Expenditures in Patients Newly Diagnosed With Paroxysmal Supraventricular Tachycardia by Sacks, Naomi C., Cyr, Philip L., Preib, Madison T., Everson, Katie, Wood, David R., Raza, Sajjad, Pokorney, Sean D.

“…Information on paroxysmal supraventricular tachycardia (PSVT) patient characteristics and the associated economic burden of the disease is limited. Therefore,…”
Get full text

Costs and health resource use in patients with X-linked myotubular myopathy: insights from US commercial claims by Sacks, Naomi C, Healey, Bridget E, Cyr, Philip L, Slocomb, Theodore, James, Emma, Beggs, Alan H, Graham, Robert J

“…In X-linked myotubular myopathy (XLMTM), mutations in the gene result in absence or dysfunction of myotubularin, a protein required for normal development,…”
Get full text

Burden of Acute Myeloid Leukemia Among Older, Newly Diagnosed Patients: Retrospective Analysis of Data From the 2010–2012 Medicare Limited Data Set by Sacks, Naomi C., Cyr, Philip L., Louie, Arthur C., Liu, Yanmei, Chiarella, Michael T., Sharma, Abhishek, Chung, Karen C.

“…Acute myeloid leukemia (AML) disproportionately affects older adults; the prognosis in this subpopulation is generally poor, with variable use of inpatient…”
Get full text

The economic burden of NIPC and BOS following allogeneic HSCT in patients with commercial insurance in the United States by Sacks, Naomi C., Healey, Bridget E., Raza, Sajjad, Cyr, Philip L., Boerner, Gerhard, Sheshadri, Ajay

“…Noninfectious pulmonary complications (NIPC) after allogeneic hematopoietic stem cell transplantation (alloHSCT), including bronchiolitis obliterans syndrome…”
Get full text

Cost-Consequence Analysis of Using Cangrelor in High Angiographic Risk Percutaneous Coronary Intervention Patients: A US Hospital Perspective by Jensen, Ivar S., Wu, Elizabeth, Cyr, Philip L., Claussen, Marc, Winkler, Thomas, Salahuddin, Khalid, Prats, Jayne, Mahaffey, Kenneth W., Gibson, Charles Michael, Steg, Philippe Gabriel, Stone, Gregg W., Bhatt, Deepak L.

“…Objectives The objective of this study was to evaluate a US hospital’s cost implications and outcomes of cangrelor use in percutaneous coronary intervention…”
Get full text

Use of Oritavancin in Moderate-to-Severe ABSSSI Patients Requiring IV Antibiotics: A U.S. Payer Budget Impact Analysis by Jensen, Ivar S, Wu, Elizabeth, Fan, Weihong, Lodise, Thomas P, Nicolau, David P, Dufour, Scott, Cyr, Philip L, Sulham, Katherine A

“…It is estimated that acute bacterial skin and skin structure infections (ABSSSI) account for nearly 10% of hospital admissions and 3.4-3.8 million emergency…”
Get full text

Budget Impact Analysis of Using Daunorubicin-Cytarabine Liposome in Patients with Newly Diagnosed Therapy-Related AML or AML and Myelodysplasia-Related Changes by Jensen, Ivar S, Wu, Elizabeth, Sacks, Naomi C, Cyr, Philip L, Chung, Karen C

“…Current national estimates for acute myelogenous leukemia (AML) indicate this disease accounts for 1.1% of new cancer diagnoses and 1.8% of cancer deaths in…”
Get full text

Use of Oritavancin in Acute Bacterial Skin and Skin Structure Infections Patients Receiving Intravenous Antibiotics: A US Hospital Budget Impact Analysis by Jensen, Ivar S., Lodise, Thomas P., Fan, Weihong, Wu, Chining, Cyr, Philip L., Nicolau, David P, DuFour, Scott, Sulham, Katherine A.

“…Background and Objective Nearly 10 % of all US hospital admissions are attributed to acute bacterial skin and skin structure infections (ABSSSIs). While most…”
Get full text

Sa1500 Dual-Acting Osmotic and Stimulant Laxative for Bowel Cleansing: a US Commercial and Medicare Payer Budget Impact Analysis by Cyr, Philip L, Sidhu, Manpreet K, Burtea, Teodor, Hussain, Raheal, Hromin, Thomas, Pike, Irving M

Get full text

Cost-Effectiveness of Diagnostic Strategies for H. pylori Infection in a High Prevalence Population by Slawsky, Katherine, Cyr, Philip L, Olchanski, Natalia, Howden, Colin W

Get full text

Real-world comparison of the effectiveness and safety of different bowel preparation agents by Sacks, Naomi C, Sharma, Abhishek, Cyr, Philip L, Bertiger, Gerald, Dahdal, David N, Brogadir, Stuart P

“…Proper bowel cleansing is necessary prior to colonoscopy, but poor tolerability to bowel preparation agents may increase the odds of poor cleansing and…”
Get full text

Economic impact of switching to bivalirudin for a primary percutaneous coronary intervention in a US hospital by Olchanski, Natalia, Slawsky, Katherine A, Plent, Stephanie, Kado, Carla, Cyr, Philip L

“…The addition of glycoprotein IIb/IIIa inhibitors (GPIs) to heparin in percutaneous coronary intervention (PCI) procedures has been demonstrated to reduce…”
Get full text

Mo1697 REAL-WORLD EVIDENCE COMPARISON OF COLORECTAL CANCER SCREENING OUTCOMES WITH DIFFERENT BOWEL PREPARATION AGENTS IN ADULTS 65 YEARS AND OLDER by Sacks, Naomi C., Sharma, Abhishek, Cyr, Philip L., Stong, Laura, Dahdal, David N.

Get full text